These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32170603)
1. Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κB and RORγt/IL-17 Pathways. Lee HC; Liu FC; Tsai CN; Chou AH; Liao CC; Yu HP Inflammation; 2020 Jun; 43(3):962-974. PubMed ID: 32170603 [TBL] [Abstract][Full Text] [Related]
2. Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-кB pathways in vivo and in vitro. Chen T; Guo Q; Wang H; Zhang H; Wang C; Zhang P; Meng S; Li Y; Ji H; Yan T Free Radic Res; 2015; 49(12):1459-68. PubMed ID: 26514440 [TBL] [Abstract][Full Text] [Related]
3. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways. Ma MM; Li Y; Liu XY; Zhu WW; Ren X; Kong GQ; Huang X; Wang LP; Luo LQ; Wang XZ Inflammation; 2015 Aug; 38(4):1669-82. PubMed ID: 25752620 [TBL] [Abstract][Full Text] [Related]
4. Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt. Nie Y; Wang Z; Chai G; Xiong Y; Li B; Zhang H; Xin R; Qian X; Tang Z; Wu J; Zhao P Molecules; 2019 Apr; 24(8):. PubMed ID: 30999647 [TBL] [Abstract][Full Text] [Related]
5. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway. Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012 [TBL] [Abstract][Full Text] [Related]
6. Xanthoxylin Attenuates Lipopolysaccharide-Induced Lung Injury through Modulation of Akt/HIF-1α/NF-κB and Nrf2 Pathways. Liu FC; Yang YH; Liao CC; Lee HC Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201430 [TBL] [Abstract][Full Text] [Related]
8. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031 [TBL] [Abstract][Full Text] [Related]
9. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition. Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201 [TBL] [Abstract][Full Text] [Related]
10. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426 [TBL] [Abstract][Full Text] [Related]
11. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway. Huang Y; Huang L; Zhu G; Pei Z; Zhang W J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668 [TBL] [Abstract][Full Text] [Related]
12. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach. Peritore AF; D'Amico R; Siracusa R; Cordaro M; Fusco R; Gugliandolo E; Genovese T; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073872 [TBL] [Abstract][Full Text] [Related]
13. Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Chi G; Wei M; Xie X; Soromou LW; Liu F; Zhao S Inflammation; 2013 Apr; 36(2):501-11. PubMed ID: 23180366 [TBL] [Abstract][Full Text] [Related]
14. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses. Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359 [TBL] [Abstract][Full Text] [Related]
15. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871 [TBL] [Abstract][Full Text] [Related]
16. Kan X; Chen Y; Huang B; Fu S; Guo W; Ran X; Cao Y; Xu D; Cheng J; Yang Z; Xu Y J Zhejiang Univ Sci B; 2021 Nov; 22(11):929-940. PubMed ID: 34783223 [TBL] [Abstract][Full Text] [Related]
17. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways. Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920 [TBL] [Abstract][Full Text] [Related]
18. Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-κB pathway. Jiang K; Guo S; Yang C; Yang J; Chen Y; Shaukat A; Zhao G; Wu H; Deng G Int Immunopharmacol; 2018 Nov; 64():140-150. PubMed ID: 30173054 [TBL] [Abstract][Full Text] [Related]
19. Acacia catechu (L.f.) Willd and Scutellaria baicalensis Georgi extracts suppress LPS-induced pro-inflammatory responses through NF-кB, MAPK, and PI3K-Akt signaling pathways in alveolar epithelial type II cells. Feng T; Zhou L; Gai S; Zhai Y; Gou N; Wang X; Zhang X; Cui M; Wang L; Wang S Phytother Res; 2019 Dec; 33(12):3251-3260. PubMed ID: 31506998 [TBL] [Abstract][Full Text] [Related]
20. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation. Zhang Q; Zhu S; Cheng X; Lu C; Tao W; Zhang Y; William BC; Cao X; Yi S; Liu Y; Zhao Y; Luo Y Biochem Pharmacol; 2018 Sep; 155():444-454. PubMed ID: 30055150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]